|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
 |
Case ID: 4460 | Drugs / Medical | 07/05/2006
A tentative settlement was announced in a ten year old class-action lawsuit against a former Warren hospital. The suit was filed in 1995 by two former patients on behalf of 12,000 past hospital patients. The lawsuit claims medical records containing diagnoses of alcohol and drug abuse, mental illness and sexually transmitted diseases were turned over to a local law firm that wanted to help pay the hospital bills through federal Supplemental Security Income benefits.
A judgment entry from Judge Thomas Patrick Curran said plaintiffs, who sued over a breach of patient confidentiality, will be informed in the meantime to consider the latest offer from representatives of the former Warren General Hospital. Judge Curran scheduled a fairness hearing for December 16, 2005 to sort out the extent of damage against 501 plaintiffs. One of the former hospital clients found that her records had been given to a Youngstown television station by a lawfirm secretary, which also was named defendants in the suit and settled in the case in December 2003. At the time, the 501 plaintiffs each received between $400 and $800 in damages from the total $130,000 paid out by the law firm or its insurance carrier. The latest settlement, in which damages have not been announced, is between the same plaintiffs and Warren General Hospital Association, a nonprofit holding company. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Drugs / Medical Cases of Interest A class action has been filed on behalf of search and rescue, demolition and cleanup workers, as well as local residents exposed to lethal toxins at the World Trade Center site after the September 11 terrorist attacks. The suit alleges that the workers, and potentially hundreds of thousands of New Yorkers living in the immediate vicinity, contracted serious illnesses as a result of toxic exposure. The complaint further projects that many others who were exposed but do not yet show symptoms will become ill in coming years as a result of their exposure. An Indiana man is suing Sisters of St. Francis Health Services over an incident in which the personal information of more than 200,000 patients was misplaced. Lawyers are actively investigating claims of high fever and hospitalizations leading to serious illness or death associated with use of Gambro Da Vita Kidney Dialysis machines. The parties have reached a tentative settlement valued at $12,457,350 CDN in a class action filed against Bristol-Myers Squibb Canada Company and Bristol-Myers Squibb Company on behalf of all Canadian residents who purchased Stadol NS nasal spray in Canada from July 1, 1994, to July 1, 2004. The action alleged that the nasal spray is addictive and that the defendants did not adequately warn patients of the possibility of addiction. The court has apparently not yet set a claims deadline-- persons eligible to take part in the settlement should contact attorneys for the class as soon as possible. Several class actions have been filed against healthcare facility operator Dynacq International (Nasdaq: DYIIE, formerly Nasdaq: DYII) and certain of its officers and directors by stockholders who purchased the company's common stock between January 14, 2003, and December 18, 2003. The actions claim that the defendants fraudulently certified that Dynacq's financial statements for the first three quarters of fiscal 2003 were compiled in compliance with Generally Accepted Accounting Principles. The stockholders seek to recover compensatory damages for the loss of value of their stock. The FDA directed Eli Lilly and Company, the manufacturer of Strattera (atomoxetine), to revise the prescribing information to include a boxed warning and additional warning statements that alert health care providers of an increased risk of suicidal thinking in children and adolescents being treated with this medication. FDA also informed Lilly that a Patient Medication Guide (MedGuide) should be provided to patients when Strattera is dispensed. The MedGuide advises patients of the risks associated with and precautions that can be taken when Strattera is dispensed. |
IT'S FREE
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
